These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18653385)

  • 21. Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis.
    Zafranskaya M; Oschmann P; Engel R; Weishaupt A; van Noort JM; Jomaa H; Eberl M
    Immunology; 2007 May; 121(1):29-39. PubMed ID: 17239199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IFN-beta inhibits human Th17 cell differentiation.
    Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
    J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokine secretion pattern in treatment of lymphocytes of multiple sclerosis patients with fumaric acid esters.
    Zoghi S; Amirghofran Z; Nikseresht A; Ashjazadeh N; Kamali-Sarvestani E; Rezaei N
    Immunol Invest; 2011; 40(6):581-96. PubMed ID: 21510778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis.
    Ishizu T; Osoegawa M; Mei FJ; Kikuchi H; Tanaka M; Takakura Y; Minohara M; Murai H; Mihara F; Taniwaki T; Kira J
    Brain; 2005 May; 128(Pt 5):988-1002. PubMed ID: 15743872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment with type I interferons induces a regulatory T cell subset in peripheral blood mononuclear cells from multiple sclerosis patients.
    Pentón-Rol G; Cervantes-Llanos M; Cabrera-Gómez JA; Alonso-Ramírez R; Valenzuela-Silva C; Rodríguez-Lara R; Montero-Casimiro E; Bello-Rivero I; López-Saura P
    Int Immunopharmacol; 2008 Jun; 8(6):881-6. PubMed ID: 18442793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expansion of CD4+CD28- T cells producing high levels of interferon-{gamma} in peripheral blood of patients with multiple sclerosis.
    Miyazaki Y; Iwabuchi K; Kikuchi S; Fukazawa T; Niino M; Hirotani M; Sasaki H; Onoé K
    Mult Scler; 2008 Sep; 14(8):1044-55. PubMed ID: 18573819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression.
    Krakauer M; Sorensen P; Khademi M; Olsson T; Sellebjerg F
    Mult Scler; 2008 Jun; 14(5):622-30. PubMed ID: 18424480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-gamma secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-beta therapy.
    Becher B; Giacomini PS; Pelletier D; McCrea E; Prat A; Antel JP
    Ann Neurol; 1999 Feb; 45(2):247-50. PubMed ID: 9989628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects.
    Correale J; Arias M; Gilmore W
    J Immunol; 1998 Oct; 161(7):3365-74. PubMed ID: 9759853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls.
    Vanderlocht J; Hendriks JJ; Venken K; Stinissen P; Hellings N
    J Neuroimmunol; 2006 Aug; 177(1-2):189-200. PubMed ID: 16797728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effect of interferon-beta treatment in patients with multiple sclerosis is associated with transient increase in serum IL-6 level in response to interferon-beta injection.
    Nakatsuji Y; Nakano M; Moriya M; Kishigami H; Tatsumi C; Tada S; Sadahiro S; Naka T; Mitani K; Funauchi M; Azuma T; Watanabe S; Kinoshita M; Kajiyama K; Yuasa Y; Kaido M; Takahashi MP; Naba I; Hazama T; Sakoda S;
    Cytokine; 2006 Oct; 36(1-2):69-74. PubMed ID: 17161613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals.
    Berthelot L; Laplaud DA; Pettré S; Ballet C; Michel L; Hillion S; Braudeau C; Connan F; Lefrère F; Wiertlewski S; Guillet JG; Brouard S; Choppin J; Soulillou JP
    Eur J Immunol; 2008 Jul; 38(7):1889-99. PubMed ID: 18506883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antidepressants suppress production of the Th1 cytokine interferon-gamma, independent of monoamine transporter blockade.
    Diamond M; Kelly JP; Connor TJ
    Eur Neuropsychopharmacol; 2006 Oct; 16(7):481-90. PubMed ID: 16388933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical response to glatiramer acetate correlates with modulation of IFN-gamma and IL-4 expression in multiple sclerosis.
    Valenzuela RM; Costello K; Chen M; Said A; Johnson KP; Dhib-Jalbut S
    Mult Scler; 2007 Jul; 13(6):754-62. PubMed ID: 17613604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the immunogenicity of different interferon beta-1a formulations using ex vivo T-cell assays.
    Jaber A; Baker M
    J Pharm Biomed Anal; 2007 Mar; 43(4):1256-61. PubMed ID: 17118612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The HLA-DR2 haplotype is associated with an increased proliferative response to the immunodominant CD4(+) T-cell epitope in human interferon-beta.
    Stickler M; Valdes AM; Gebel W; Razo OJ; Faravashi N; Chin R; Rochanayon N; Harding FA
    Genes Immun; 2004 Jan; 5(1):1-7. PubMed ID: 14735143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-beta modifies the peripheral blood cell cytokine secretion in patients with multiple sclerosis.
    Mirandola SR; Hallal DE; Farias AS; Oliveira EC; Brandão CO; Ruocco HH; Damasceno BP; Santos LM
    Int Immunopharmacol; 2009 Jul; 9(7-8):824-30. PubMed ID: 19289181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic immune responses induced by endogenous retrovirus and herpesvirus antigens result in increased production of inflammatory cytokines in multiple sclerosis patients.
    Brudek T; Christensen T; Hansen HJ; Petersen T; Møller-Larsen A
    Scand J Immunol; 2008 Mar; 67(3):295-303. PubMed ID: 18261041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis.
    Mehling M; Brinkmann V; Antel J; Bar-Or A; Goebels N; Vedrine C; Kristofic C; Kuhle J; Lindberg RL; Kappos L
    Neurology; 2008 Oct; 71(16):1261-7. PubMed ID: 18852441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.
    Durelli L; Conti L; Clerico M; Boselli D; Contessa G; Ripellino P; Ferrero B; Eid P; Novelli F
    Ann Neurol; 2009 May; 65(5):499-509. PubMed ID: 19475668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.